Cathie Wood’s ARK line of ETFs made some significant trades yesterday, selling Palantir Technologies (PLTR) and Robinhood ...

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report) had its price target lowered by equities researchers at Needham & Company LLC from $38.00 to $10.00 in a report released on Monday,Benzinga reports.

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “hold” rating restated by research analysts at Canaccord Genuity Group in a note issued to investors on Monday, MarketBeat reports.

Check out the latest The Pnc Financial Services Group Inc. (PNC) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.

Canaccord Genuity has downgraded Pliant (PLRX) to hold following news that the company has paused a clinical trial for its ...

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pliant ...

Fintel reports that on February 10, 2025, Canaccord Genuity downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) ...

Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.

On Monday, February 10, 2025, the Cathie Wood-led Ark Invest sold nearly $16 million worth of Palantir shares amid a spike in ...

The Dow Jones Industrial Average and other major index futures traded mixed Tuesday, as China retaliated against President Donald Trump's tariffs. One stock that managed a big gain on the stock market ...

That’s because it’s gradually dawning on investors that they no longer can count on lower interest rates and inflation to support higher stock and bond prices. They are realizing that ...

Shares of Netflix rose 13% in afterhours trading as investors cheered the company's first U.S. price hike since 2023. The streaming service's move aims to capitalize on surging demand and sharp ...